dimecres, 18 de febrer del 2015

Allergan name to live on post Actavis merger




Actavis CEO Brent Saunders tells CNBC that the company will adopt the Allergan name once the $66 billion merger closes.





Ackman supports Allergan's $66B sale to Actavis

Actavis, Allergan Inc.

News Well, Mergers & Acquisitions

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/19x277G
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)